Search research articles
Contact Us
Filters
Showing results (1-10 of 260) with videos related to
Page
of 26
Sort By:
Contemporary Clinical Trials
|
June 21, 2014
Identifying cut points for biomarker defined subset effects in clinical trials with survival endpoints
Pei He
Zhonghua Yi Xue Za Zhi
|
December 17, 2008
[More research is needed to understand the airway inflammation in chronic obstructive pulmonary disease]
Pei He
Contemporary Clinical Trials Communications
|
May 9, 2018
A novel design for randomized immuno-oncology clinical trials with potentially delayed treatment effects
Pei He, Zheng Su
British Medical Bulletin
|
April 30, 2015
Reinventing clinical trials: a review of innovative biomarker trial designs in cancer therapies
Ja-An Lin, Pei He
Statistics in Medicine
|
August 31, 2012
A sequential testing approach to detecting multiple change points in the proportional hazards model
Pei He, Liang Fang, Zheng Su
Molecular and Cellular Biochemistry
|
January 3, 2020
MicroRNA-9119 regulates cell viability of granulosa cells in polycystic ovarian syndrome via mediating Dicer expression
Yang Ding, Pei He, Zhiling Li
Contemporary Clinical Trials
|
May 14, 2013
Estimating the survival functions for right-censored and interval-censored data with piecewise constant hazard functions
Pei He, George Kong, Zheng Su
The Journal of International Medical Research
|
September 23, 2020
Serum apolipoprotein A-II and alpha-2-antiplasmin levels in midtrimester can be used as predictors of preterm delivery
Jianxia Huang, Yuhong Yang, Pei He
ACS Applied Materials & Interfaces
|
August 18, 2022
Stability Bounds for Micron Scale Ag Conductor Lines Produced by Electrohydrodynamic Inkjet Printing
Jinxin Yang, Pei He, Brian Derby
Contemporary Clinical Trials
|
June 3, 2015
Design of clinical trials with failure-time endpoints and interim analyses: An update after fifteen years
Pei He, Tze Leung Lai, Zheng Su
Page
of 26
Search research articles
Search
Showing results (1-10 of 260) with videos related to
Sort By:
Page
of 26
Contemporary Clinical Trials
|
June 21, 2014
Identifying cut points for biomarker defined subset effects in clinical trials with survival endpoints
Pei He
Zhonghua Yi Xue Za Zhi
|
December 17, 2008
[More research is needed to understand the airway inflammation in chronic obstructive pulmonary disease]
Pei He
Contemporary Clinical Trials Communications
|
May 9, 2018
A novel design for randomized immuno-oncology clinical trials with potentially delayed treatment effects
Pei He, Zheng Su
British Medical Bulletin
|
April 30, 2015
Reinventing clinical trials: a review of innovative biomarker trial designs in cancer therapies
Ja-An Lin, Pei He
Statistics in Medicine
|
August 31, 2012
A sequential testing approach to detecting multiple change points in the proportional hazards model
Pei He, Liang Fang, Zheng Su
Molecular and Cellular Biochemistry
|
January 3, 2020
MicroRNA-9119 regulates cell viability of granulosa cells in polycystic ovarian syndrome via mediating Dicer expression
Yang Ding, Pei He, Zhiling Li
Contemporary Clinical Trials
|
May 14, 2013
Estimating the survival functions for right-censored and interval-censored data with piecewise constant hazard functions
Pei He, George Kong, Zheng Su
The Journal of International Medical Research
|
September 23, 2020
Serum apolipoprotein A-II and alpha-2-antiplasmin levels in midtrimester can be used as predictors of preterm delivery
Jianxia Huang, Yuhong Yang, Pei He
ACS Applied Materials & Interfaces
|
August 18, 2022
Stability Bounds for Micron Scale Ag Conductor Lines Produced by Electrohydrodynamic Inkjet Printing
Jinxin Yang, Pei He, Brian Derby
Contemporary Clinical Trials
|
June 3, 2015
Design of clinical trials with failure-time endpoints and interim analyses: An update after fifteen years
Pei He, Tze Leung Lai, Zheng Su
Page
of 26